The Chinese pharmaceutical market, although only positioned ninth globally, has experienced pronounced and rapid expansion in recent years, driven by the growth of both Chinese and Western manufacturers. Increasingly, there is a shift towards a research-based industry, focused on generating new, innovative therapies, supported by improving intellectual property regulations.
Scope of this report
Overview of macro-environmental and regulatory issues affecting the Chinese pharmaceutical industry
Assessment of the Chinese pharmaceutical market, analyzing the key prescription therapy areas, as well as OTC and TCM medicines
Case study analysis of key Western and Chinese manufacturers in China
Insight into the key opportunities for Western manufacturers in China, and the areas likely to provide revenue growth in the future
Research and analysis highlights
With improvements in intellectual property regulations, Government funding and the growth of tax incentivized Special Economic Zones, China's R&D environment is developing fast. Western manufacturers are increasingly looking towards China as a place to conduct drug discovery and clinical trial research, although a number of challenges still remain.
China is becoming an increasingly competitive environment due to ongoing price competition, and numerous Governmental price cuts. Unless Western manufacturers have Chinese based manufacturing plants which can produce generic drugs at low-cost, there is little financial incentive or future prospects for foreign companies in the generics market.
China still exemplifies the disease and treatment profile of a developing market, with a focus on prescribing anti-infectives. However, with westernization of diet and lifestyle, and China's improving healthcare system, treatment of more chronic disorders will eventually become more of a priority in the future.
Key reasons to read this report
Understand the dynamics of the Chinese pharmaceutical market and the effect of recent changes to pricing, reimbursement and patent regulations
Identify China's R&D attractions, which are encouraging Western manufacturers to off-shore and out source drug discovery and clinical trials in China
Optimize your Chinese market growth strategy through detailed knowledge of the performance of the Chinese and Western manufacturers in China
For more information, Please visit :
http://www.bharatbook.com/
